Drug Shortage Report for UROMITEXAN
Report ID | 155660 |
Drug Identification Number | 02241411 |
Brand name | UROMITEXAN |
Common or Proper name | Uromitexan |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | MESNA |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | ORAL INTRAVENOUS ORAL INTRAVENOUS |
Packaging size | 15 ampoules / box (Product Code: 2639B2010) |
ATC code | V03AF |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-02-25 |
Actual start date | 2022-02-25 |
Estimated end date | 2022-03-30 |
Actual end date | 2022-03-30 |
Shortage status | Resolved |
Updated date | 2022-03-31 |
Company comments | UROMITEXAN (mesna) Injection 400 mg/4 mL (100mg/mL). Box of 15 ampoules. Baxter code 2639B2019 can be used as a substitute. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2022-03-31 | English | Compare |
v13 | 2022-03-30 | French | Compare |
v12 | 2022-03-30 | English | Compare |
v11 | 2022-03-25 | French | Compare |
v10 | 2022-03-25 | English | Compare |
v9 | 2022-03-22 | French | Compare |
v8 | 2022-03-22 | English | Compare |
v7 | 2022-03-21 | French | Compare |
v6 | 2022-03-21 | English | Compare |
v5 | 2022-03-15 | French | Compare |
v4 | 2022-03-15 | English | Compare |
v3 | 2022-02-26 | English | Compare |
v2 | 2022-02-25 | French | Compare |
v1 | 2022-02-25 | English | Compare |
Showing 1 to 14 of 14